EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

After multiple cases of Guillain-Barré Syndrome were reported in Pune, Mumbai has now recorded its first case—a 64-year-old ...

Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Brist ...

CMV, yet another causative agent of GBS is also ... Patients with GBS triggered by Mycoplasma pneumoniae may present with respiratory symptoms, such as cough and sore throat, preceding ...

Guillain-Barré Syndrome (GBS) is a rare condition that affects the nerves. It can lead to weakness, numbness and, in severe cases, even paralysis. GBS is most common in children and young adults. Dr ...

Guillain Barré Syndrome overview: symptoms, causes, treatment, and potential complications, including recent outbreak in Pune ...

Secondary (nonmendelian) HLH is an acquired condition, mainly seen in adults, that is most often ... 17 The signs and symptoms of all forms of HLH are generally quite similar, and it is often ...

The condition of the sole Guillain-Barré Syndrome (GBS) patient in Mumbai, who is undergoing treatment in civic-run Seven Hills Hospital of Marol, is stable now, Andheri East legislator Murji Patel ...

The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Iremide Kasali, a 5-year-old girl, came into the world with cataract, but her parents did not come to terms with the condition early enough.